Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5584935 | Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) | 2017 | 8 Pages |
Abstract
Higher levels of DHA+EPA may help protect against the development of dementia. Results from prospective randomized controlled trials of DHA+EPA supplementation are needed to help clarify whether this association is causal.
Keywords
CEEEPAWHIMS3MSWomen's Health Initiative Memory StudyRBCmild cognitive impairmentconjugated equine estrogensEicosapentaenoic aciddocosahexaenoic acidFatty acidOmega-3 fatty acidsstandard deviationAlzheimer's diseaseDHAWomenconfidence intervalCohort studieshazard ratioBiomarkersMCIAll cognitive disorders/dementiaHormone therapyred blood cell
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Eric M. Ammann, James V. Pottala, Jennifer G. Robinson, Mark A. Espeland, William S. Harris,